- Report
- June 2024
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Dequalinium is a drug used to treat a variety of infectious diseases, including bacterial and fungal infections. It is an antiseptic and bacteriostatic agent, meaning it can both kill and inhibit the growth of bacteria. It is also used to treat trachoma, a common eye infection caused by the bacterium Chlamydia trachomatis. Dequalinium is available in both oral and topical forms, and is often used in combination with other antibiotics.
The Dequalinium market is highly competitive, with many companies offering their own formulations of the drug. Companies such as Pfizer, Merck, and GlaxoSmithKline are some of the major players in the market. Other companies such as Novartis, Sanofi, and Bayer also offer Dequalinium-based products. Generic versions of the drug are also available from many generic drug manufacturers. Show Less Read more